Emmessar Biotech & Nutrition Ltd Announces Unaudited Q2 FY26 Results and Details AGM Schedule
Emmessar Biotech & Nutrition Limited announced the unaudited financial results for the quarter ended June 30, 2026. The results were reviewed by the Statutory Auditors, M/s. V. Nagarajan & Co., who issued a Limited Review Report dated August 7, 2026, in respect of the performance.The Board of Directors approved these results during its meeting held on August 7, 2026. The company also provided details regarding the forthcoming Annual General Meeting (AGM) and associated e-voting procedures.
Q2 FY26 Financial Performance
The unaudited results for the quarter ended June 30, 2026, reflected a total income of 59.85 million rupees, derived from a revenue from operations of 593 million rupees and other income of 53.92 million rupees. Expenses totaled 43.55 million rupees, leading to a profit before tax of 16.30 million rupees. The net profit after tax recorded for the period was 13.15 million rupees.The financial summary, including key metrics from different reporting periods, is presented in the table below:
| Particulars | Q Ended 30.06.2026 (Unaudited) | Q Ended 31.03.2026 (Audited) | Q Ended 30.06.2025 (Unaudited) | Y Ended 31.03.2026 (Audited) |
|---|---|---|---|---|
| Revenue from Operations | 593 | 9.28 | 9.28 | 37.08 |
| Total Income | 59.85 | 56.62 | 62.70 | 240.66 |
| Total Expenses | 43.55 | 48.67 | 39.57 | 18270 |
| Profit Before Tax & Exceptional Items | 16.30 | 7.96 | 23.13 | 57.96 |
| Net Profit/Total Comprehensive Income | 13.15 | - | 17.12 | 40.67 |
Segmentwise Results for Qended June 30, 2026
The company operates in two segments: Healthcare and Rent on Leasehold Land, alongside Others. The segment performance for the quarter ended June 30, 2026, was as follows:| Segment | Revenue (Rs. In Lakhs) |
|---|---|
| Healthcare | 593 |
| Rent on Leasehold Land | 4133 |
| Others | 12.59 |
| Total | 59.85 |
AGM and E-Voting Details
The company has scheduled the 34th Annual General Meeting (AGM) to be held on Tuesday, September 29, 2025. The meeting will be conducted through a VC/OAVM facility, with the Registered Office of the Company serving as the deemed venue for the AGM.In adherence to regulatory requirements, the company has established an electronic voting system managed by MUFG Intime India Private Limited. The cutoff date for limited purpose remote e-voting is September 22, 2026. The remote e-voting period will commence on Saturday, September 26, 2026, at 09:00 A.M. IST and conclude on Monday, September 28, 2026, at 5:00 P.M IST.
Stock Price Movement
At 13:45, Emmessar Biotech & Nutrition Ltd is ticking down at ₹24.87, reflecting a loss of 2.09% in the ongoing trading session. The shares have seen intraday movement, ranging from a low of ₹24.24 up to a high of ₹24.88.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.